Is melatonin safe for children who can't sleep?

Debate continues over melatonin, a sleep aid widely used by both children and adults. Some claim it boosts immunity, while ...
Medindia

Neurocrine Biosciences Initiates Phase 2 Study of Crinecerfont in Pediatric Patients Under 4 Years Old with Classic Congenital Adrenal Hyperplasia

Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced the initiation of its Phase 2 clinical study to assess the safety and tolerability of crinecerfont in children aged 3 months to under 4 ...
Medscape

Androgenetic Alopecia Often Missed in Teens

Androgenetic alopecia is the most common form of hair loss in adolescents but often goes unrecognized even as new treatments ...
Opinion
The LancetOpinion

From PCOS to PMOS: perspectives on the new nomenclature

Helena J Teede and colleagues’ global consensus to rename polycystic ovary syndrome (PCOS) as polyendocrine metabolic ovarian syndrome (PMOS) is an important advance.1 The previous term is ...
oskaloosa.com

Central biology professor, alum publish national article

PELLA —Central College professor Nicole Palenske Ladner and 2024 graduate Peyton Bytnar co-authored an article published by the National Science Teaching Association titled "Something's Not Right: An ...
The Lancet

[177 Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial

Lu]Lu-edotreotide led to statistically significant and clinically meaningful improvements in progression-free survival.